EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dendrimers Improve Apolipoprotein Nanoparticle mRNA Delivery to Immune Cells

Mirre M Trines iD, Daniek Hoorn iD, Stijn R J Hofstraat iD, Robby C Zwolsman iD, Tom Anbergen iD, Iris Versteeg, Yuri van Elsas iD, Jeroen Deckers iD, Merel M A Hendrikx iD, Teun Kleuskens, Youssef B Darwish, Gijs W B Ros und 13 weitere

Advanced Materials · 2026-01 · 38 (3)

DOI: 10.1002/adma.202504830 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 12.09.2025. Verfasst von Mirre M Trines und 24 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems (ICMS), Eindhoven University of Tech…. Hauptthemen laut MEDLINE: Dendrimers, Nanoparticles, RNA, Messenger, Drug Carriers. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: H2020 European Research Council, Dutch Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Employing messenger RNA (mRNA) for protein production in the liver or for vaccine purposes is a promising therapeutic approach. However, unlocking mRNA's full therapeutic potential requires systemic delivery platform technology with controllable biodistribution features. Apolipoprotein nanoparticles (aNP) containing monovalent ionizable cationic lipids have been shown to functionally deliver mRNA to myeloid progenitor cells in the bone marrow after intravenous administration. Here, the development of polyvalent ionizable cationic dendrimers is reported for incorporation in aNPs to enable efficient mRNA complexation and functional delivery. A library of dendrimers is first rationally designed with diverse hydrophobic core units, a number of branching units, and functionalized terminal units. Upon incorporation, eleven distinct dendrimer‐based aNP‐mRNA formulations are screened and characterized in vitro for their properties. Based on the screening outcome, four formulations are selected and evaluated their ability to induce functional gene expression in vivo. The results indicate that the lead polyvalent dendrimer‐based aNP formulation outperformed formulations containing a clinically approved ionizable cationic lipid regarding gene expression in hematopoietic stem and progenitor cells in the bone marrow after intravenous administration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DendrimersNanoparticlesRNA, MessengerDrug CarriersAnimalsMiceHumansHematopoietic Stem Cells

Stichwörter der Autor:innen

apolipoprotein nanoparticlesdendrimersionizable cationic lipidsmRNA delivery

Substanzen

DendrimersRNA, MessengerDrug Carriers

Autor:innen und Institutionen

  • Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, Eindhoven, 5600 MB, The Netherlands.
  • Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI), Radboud University Medical Center, Nijmegen, 6525 GA, The Netherlands.
  • Biotrip B.V., Eindhoven, 5641 AM, The Netherlands.
  • SyMO-Chem B.V., Eindhoven, 5612 AZ, The Netherlands.
  • Laboratory of Macromolecular and Organic Chemistry, Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, Eindhoven, 5600 MB, The Netherlands.

ORCID-Profile: Mirre M Trines, Daniek Hoorn, Stijn R J Hofstraat, Robby C Zwolsman, Tom Anbergen, Yuri van Elsas, Jeroen Deckers, Merel M A Hendrikx, Sjoerd F Dijkstra, Bram Priem, Matt Timmers, E W Meijer, Thijs J Beldman, Ewelina Kluza, Willem J M Mulder, Roy van der Meel

Förderung

  • H2020 European Research Council
  • Dutch Research Council

Zitieren

APA

Trines, M. M., Hoorn, D., Hofstraat, S. R. J., Zwolsman, R. C., Anbergen, T., Versteeg, I., van Elsas, Y., Deckers, J., Hendrikx, M. M. A., Kleuskens, T., Darwish, Y. B., Ros, G. W. B., Dijkstra, S. F., Priem, B., Timmers, M., Fransen, P. M., Pouderoijen, M. J., de Waal, B. F. M., Meijer, E. W., …, & van der Meel, R. (2026). Dendrimers Improve Apolipoprotein Nanoparticle mRNA Delivery to Immune Cells. Advanced Materials, 38(3). https://doi.org/10.1002/adma.202504830

Vancouver

Trines MM, Hoorn D, Hofstraat SRJ, Zwolsman RC, Anbergen T, Versteeg I, et al. Dendrimers Improve Apolipoprotein Nanoparticle mRNA Delivery to Immune Cells. Advanced Materials. 2026;38(3). doi:10.1002/adma.202504830

BibTeX
@article{Trines2026,
  author = {Trines, Mirre M and Hoorn, Daniek and Hofstraat, Stijn R J and Zwolsman, Robby C and Anbergen, Tom and Versteeg, Iris and van Elsas, Yuri and Deckers, Jeroen and Hendrikx, Merel M A and Kleuskens, Teun and Darwish, Youssef B and Ros, Gijs W B and Dijkstra, Sjoerd F and Priem, Bram and Timmers, Matt and Fransen, P Michel and Pouderoijen, Maarten J and de Waal, Bas F M and Meijer, E W and Beldman, Thijs J and Toner, Yohana C and Kluza, Ewelina and Mulder, Willem J M and Janssen, Henk M and van der Meel, Roy},
  title = {Dendrimers Improve Apolipoprotein Nanoparticle mRNA Delivery to Immune Cells},
  journal = {Advanced Materials},
  year = {2026},
  volume = {38},
  number = {3},
  doi = {10.1002/adma.202504830}
}
Kostenlos starten →